BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 13 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ibex Investors LLC | 322,413 | $12,603,000 | 6.64% |
MORGAN JESS S & CO INC | 74,464 | $2,911,000 | 2.90% |
Mutual Advisors, LLC | 7,151 | $280,000 | 0.02% |
BANK HAPOALIM BM | 6,510 | $254,000 | 0.01% |
NEXT Financial Group, Inc | 1,350 | $53,000 | 0.01% |
ARK Investment Management | 19,856 | $776,000 | 0.01% |
HighTower Advisors, LLC | 17,900 | $701,000 | 0.00% |
Edge Wealth Management LLC | 250 | $10,000 | 0.00% |
CAPTRUST FINANCIAL ADVISORS | 1,190 | $47,000 | 0.00% |
ROYAL BANK OF CANADA | 3,607 | $141,000 | 0.00% |